A 35-year-old male was referred to our institution with the diagnosis of an anterior cranial fossa lesion. He had been suffering consistent headache, numbness in the left half of his face, and anosmia for 3 months. There was no facial swelling or asymmetry. He did not express any pain during mastication or any difficulty in jaw movements. His symptoms had rapidly progressed in the last 3 weeks. The patient had undergone transsphenoidal biopsy elsewhere before presenting to our clinic of and the pathology result had been AC. The patient's paranasal computed tomography (CT) scan revealed a soft tissue mass that almost completely occupied the ethmoid cells, nasal cavity, sphenoid and left maxillary █ 
INTRODUCTION
A meloblastoma is benign, slowly growing, but locally aggressive neoplasm that constitutes about 1-3% of all jaw tumors and cysts (18) . Ameloblastic carcinoma (AC) is an exceptionally rare and aggressive malignant epithelial odontogenic tumor with a poor prognosis that may arise de novo or from malign transformation of a longstanding ameloblastomas (9, 13) . Two thirds of these tumors arise from the mandible while one third originates from maxilla (12) . AC may also present as a benign cystic lesion or as a large tissue mass with ulceration, bone destruction and may cause unstable teeth (1) . In contrast to ameloblastoma case presentations that are commonly published in the literature, AC cases and especially those arising from the mandible are rare (2, 10) . Whether this tumor transforms from ameloblastoma or represents a separate entity is still controversial (10) . Likewise, there is still no consensus on the management of AC's. However, widespread surgical excision as much as possible with or without radiotherapy is currently the preferred treatment modality (6, 16) .
Ameloblastic carcinoma (AC) is a rare and aggressive malignant epithelial odontogenic tumor that may arise either from the mandible (66.6%) or the maxilla (33.3%). Besides being formed de novo, the tumor can develop from a pre-existing ameloblastoma or odontogenic cyst. The clinical course of AC is typically aggressive with extensive local destruction. AC has also been reported to spread to various parts of the body through lymphatic system. Skull base location and intracranial extension of this tumor are uncommon. In this case report we present the clinical course, management and follow up of an uncommonly large AC that destructed the anterior skull base and extended into the intracranial space.
KEywORDS: Ameloblastic carcinoma, Skull base, Intracranial sinuses and also destructed the lamina paprecea, clivus, and cribriform plate with intracranial extension (Figure 1 ). Cranial magnetic resonance imaging (MRI) displayed the lesion as a solid, lobulated mass enhancing heterogeneously with contrast that showed a similar extension pattern as seen on the CT by means of compressing both basal frontal lobes ( Figure  2) . A CT-angiography was performed to rule out any vascular involvement such as internal carotid arteries (ICAs) and to identify the vascularity of the tumor. On CT-angiography, the tumor was found to be considerably vascular and the ICA's did not show any displacement or involvement by the tumor. Laboratory findings including tumor markers were within the normal range.
First, we planned to approach the tumor inferiorly by aiming as much gross total resection as possible. The patient underwent an extended endoscopic endonasal transsphenoidal surgery through the binostril route. The tumor was reached easily in the nasal cavity. With the help of suction/coagulation and tumor-forceps, the tumor was removed piece by piece. All tumor parts invading the nasal cavity, the maxillary sinus, the sphenoidal sinus, and the clivus were gross totally removed. Additionally, the tumor-invaded anterior cranial fossa dura mater was also excised. Although the tumor was soft in nature, its highly vascular intrastructure prevented more extensive removal and the intracranial part was left as residue. The dura mater defect was repaired with autologous graft. Postoperative early cranial MRI showed the remnant in the anterior cranial fossa (Figure 3) . Histopathological examination revealed an ameloblastic carcinoma, which was consistent with the previous biopsy evaluation (Figure 4A-D) . As the second step, a transcranial approach was planned on the third postoperative day for removal of the residual tumor since AC characteristically has a poor prognosis and is locally aggressive. A gross total resection with dura excision was performed through the right subfrontal approach ( Figure 5 ). No CSF leakage or any other complications were observed after the procedures and the patient was discharged on the 4 th day after the second operation. The patient received 5000 cGy of local adjuvant radiotherapy. The patient was followed up closely and there was no recurrence at the 18-months follow-up ( Figure 6 ).
█ DISCUSSION Ameloblastic carcinomas are rare lesions. Moreover, their presentations as intracranial extension are uncommon although AC's usually show an aggressive clinical course with a poor prognosis. AC's are recognized as malignant epithelial odontogenic tumor that may occur de novo or arise from malignant transformation of a long-standing ameloblastoma (9, 13) . Most of these tumors originate from the mandible (2/3) and the rest from the maxilla (12) . AC may also present as a benign cystic lesion or as a large tissue mass with ulceration, bone destruction and may cause unstable teeth (1). 
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locate frequently in the posterior portion of the mandible, and maxillary involvement is less common (4) . Ameloblastic carcinoma occurs in a wide range of age groups without gender predilection (4) .
Ameloblastic carcinomas have a more aggressive clinical course than typical ameloblastomas. Bone destructions, surrounding tissue invasions and cervical lymph node metastases can be associated with these lesions (4). Involvement of the nasal cavity usually relates to local invasion of the maxillary ACs. Destruction of the skull base and extension into the intracranial space are unusual and infrequently reported in the literature (13) . In this manner, the presented case displays an illustrative example and accordingly AC's may be taken into account in the differential diagnosis of lesions located in the anterior skull base.
The management of AC's is still controversial. Surgical excision with or without adjuvant radiotherapy is the most
The histogenesis of AC's and other odontogenic tumors are poorly understood. These lesions may originate from the pluripotent cells of the basal layer of the oral and sinonasal epithelium and may also originate from ectopic teeth in the nasal cavity (14, 15, 20) . The embryological developments of the sinonasal tract and the odontogenic apparatus are closely related to each other. The oral cavity and sinonasal tract communicate with each other from the 10 th intrauterine week (12) . These cavities are separated by the development of the palatine shelves. During the separation of the cavities, the odontogenic epithelium may be trapped in the sinonasal mucosa, or the sinonasal cells may acquire the capability of odontogenesis (7).
Thoma considered AC as a subtype of the ameloblastoma that displays malignant transformation (19) . The relevant literature showed that they may occur either de novo or may arise from a pre-existing odontogenic lesion (3, 17) . The tumors preferable common treatment modality (6, 16) . While most ameloblastic carcinomas are located intraosseously, the effectiveness of radiotherapy must be evaluated meticulously (10). Chemotherapy is not clearly indicated as primary treatment. En bloc removal with 1-2 cm of healthy bone margin is the safest surgical modality to provide disease-free survival and this resection maintains local recurrence rates of less than 15% (5). AC usually recurs locally 0.5-11 years after final treatment. Laughlin (11) observed that the disease-free interval between the initial diagnosis and the appearance of metastases was 9 years. However, once the metastasis has occurred, the median survival period is about 2 years (8, 11) . Due to these features of AC's, we carried out the second operation for gross total removal of the residual tumor.
█ CONClUSION AC is a rare entity that has a very invasive character and can be destructive to adjacent tissues. Infrequently, the tumor may extend into the cranial space. In the management of AC, surgical treatment in which total or gross total removal of the tumor should be aimed has priority. Adjuvant local radiotherapy may be applied after surgery but this issue is still controversial because of inadequate knowledge. When residue or recurrence is encountered, re-operation may be considered. Patients treated for AC's must be closely followed up with repeated cranial MRI's.
